Biotech · Private company
BeOne Medicines
Track this companyFree. Adds BeOne Medicines to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs61From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline61
- 5-fluorouracil (5-FU)Phase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AbemaciclibPhase 3 · HR+/HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- bendamustinePhase 3 · Mantle Cell Lymphoma; Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- BGB-43395Phase 3 · HR+/HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Intravenous TislelizumabPhase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 3 · Relapsed/Refractory Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- LetrozolePhase 3 · HR+/HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 3 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 3 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 3 · Relapsed/Refractory Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PalbociclibPhase 3 · HR+/HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- RibociclibPhase 3 · HR+/HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- rituximabPhase 3 · Mantle Cell Lymphoma; Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 3 · Relapsed/Refractory Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 3 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- SonrotoclaxPhase 3 · Mantle Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- SonrotoclaxPhase 3 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- SonrotoclaxPhase 3 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- Subcutaneous TislelizumabPhase 3 · Metastatic Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 3 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 3 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- zanubrutinibPhase 3 · Mantle Cell Lymphoma; Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 3 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 3 · Relapsed/Refractory Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 3 · Mantle Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 5-fluorouracil (5-FU)Phase 2 · Advanced Unresectable Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Advanced Unresectable Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CarfilzomibPhase 2 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DaratumumabPhase 2 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 2 · Advanced Unresectable Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 2 · Advanced Unresectable Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PomalidomidePhase 2 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SonrotoclaxPhase 2 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SonrotoclaxPhase 2 · Waldenstrom MacroglobulinemiaClinicalTrials.gov · fetched Nov 12, 2026
- TacabrutidegPhase 2 · B-cell MalignancyClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 2 · Advanced Unresectable Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 2 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 2 · Waldenstrom MacroglobulinemiaClinicalTrials.gov · fetched Nov 12, 2026
- Anti-Diarrheal AgentPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BG-89894Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BG-C477Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BGB-26808Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BGB-43395Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BGB-43395Phase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- BGB-58067Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CelecoxibPhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- ChemotherapyPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ChemotherapyPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Dabigatran etexilatePhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- ElacestrantPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LetrozolePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- RAS(ON) InhibitorsPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Tacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)PHASE2 · NOT_YET_RECRUITING · started Jan 1, 2027ClinicalTrials.gov NCT07887061 · fetched Nov 12, 2026
- A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell LymphomaPHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07799220 · fetched Nov 12, 2026
- A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395PHASE1 · RECRUITING · started Sep 25, 2026ClinicalTrials.gov NCT07820891 · fetched Nov 12, 2026
- AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal AdenocarcinomasPHASE2 · RECRUITING · started Jul 20, 2026ClinicalTrials.gov NCT07290985 · fetched Nov 12, 2026
- A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic CancerPHASE1 · RECRUITING · started Jun 22, 2026ClinicalTrials.gov NCT07671339 · fetched Nov 12, 2026
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseasePHASE3 · RECRUITING · started May 22, 2026ClinicalTrials.gov NCT07492641 · fetched Nov 12, 2026
- A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United StatesPHASE2 · RECRUITING · started Apr 30, 2026ClinicalTrials.gov NCT07554521 · fetched Nov 12, 2026
- A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic LeukemiaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 8, 2025ClinicalTrials.gov NCT07134088 · fetched Nov 12, 2026
- A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPHASE3 · RECRUITING · started Aug 27, 2025ClinicalTrials.gov NCT07043400 · fetched Nov 12, 2026
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)PHASE3 · RECRUITING · started Jun 11, 2025ClinicalTrials.gov NCT06943872 · fetched Nov 12, 2026
- Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell LymphomaPHASE2 · RECRUITING · started Jun 2, 2025ClinicalTrials.gov NCT06839053 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)PHASE3 · RECRUITING · started Mar 5, 2025ClinicalTrials.gov NCT06742996 · fetched Nov 12, 2026
- A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.PHASE1_PHASE2 · RECRUITING · started Jan 23, 2025ClinicalTrials.gov NCT06697184 · fetched Nov 12, 2026
- An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Jan 10, 2025ClinicalTrials.gov NCT06589596 · fetched Nov 12, 2026
- A Study of BG-C477 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Oct 3, 2024ClinicalTrials.gov NCT06596473 · fetched Nov 12, 2026
- Tislelizumab in People With Colorectal CancerPHASE2 · RECRUITING · started Jul 26, 2024ClinicalTrials.gov NCT06529523 · fetched Nov 12, 2026
- Rituximab and Zanubrutinib in Patients With Indolent B-cell LymphomasPHASE2 · RECRUITING · started Apr 19, 2024ClinicalTrials.gov NCT06350318 · fetched Nov 12, 2026
- BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsPHASE1 · RECRUITING · started Dec 1, 2023ClinicalTrials.gov NCT06120283 · fetched Nov 12, 2026
- Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 11, 2023ClinicalTrials.gov NCT06073821 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström MacroglobulinemiaPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 23, 2023ClinicalTrials.gov NCT05952037 · fetched Nov 12, 2026
- A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Sep 21, 2023ClinicalTrials.gov NCT05981703 · fetched Nov 12, 2026
- A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone LymphomaPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 10, 2022ClinicalTrials.gov NCT05100862 · fetched Nov 12, 2026
- A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaPHASE1_PHASE2 · RECRUITING · started Sep 16, 2021ClinicalTrials.gov NCT04973605 · fetched Nov 12, 2026
- A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell MalignanciesPHASE1_PHASE2 · RECRUITING · started Sep 13, 2021ClinicalTrials.gov NCT05006716 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell TransplantationPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 20, 2019ClinicalTrials.gov NCT04002297 · fetched Nov 12, 2026